$10 Million Fund is dedicated to bringing emerging healthcare innovations to market.
HOLLAND, Mich., November 28, 2017—
Genesis Innovation Group, LLC, an emerging developer of medical device technologies, today announced the formation of cultivate(MD) Capital Fund I, LLC, a venture capital fund focused on investing in early-stage healthcare companies, with special focus on medical device and orthopedic technologies. cultivate(MD) LLC is expected to manage $10M, is limited to private placements, and closed to the public. Genesis anticipates the cultivate(MD) fund to be fully operational and actively seeking companies in which to invest by early 2018.